• Microsoft Reactor (map)
  • 680 Folsom St, Suite 145
  • San Francisco, CA 94107
  • USA

Join us for a complimentary Networking Reception & Pitch Night with Innovative Digital Health Companies Visiting from the Nordics!



680 Folsom Street, Suite 145

San Francisco, CA 94103



Dr. Simon Kos, Chief Medical Officer & Senior Director, Worldwide Health---Microsoft


Dr Simon Kos is Chief Medical Officer and Senior Director, Worldwide Health, Microsoft. In this key executive role, Dr. Kos is responsible for providing clinical guidance, thought leadership, vision and strategy for Microsoft technologies and solutions in the Health and Healthcare industries. He works with industry partners and healthcare organizations around the world to improve and transform health outcomes by leveraging technology and innovation. Dr. Simon Kos joined Microsoft in 2010, bringing his expertise to the Australian health team after 17 years in the health and health IT industries. As the doctor on Microsoft's health team, he was responsible for health strategy and industry engagement. He raised awareness of the Microsoft brand, technologies, and partner community, and he works to find clinical relevance for Microsoft products. Prior to coming to Microsoft, Dr. Kos worked with global health IT companies Cerner and InterSystems as they implemented some of the largest e-Health initiatives in Australia. His responsibilities included product design and localization, clinical engagement, industry thought leadership, and team management. Before his career in health IT, Dr. Kos practiced at NSWHealth for several years with a focus on critical care. Simon has an MBBS and a BSc (Med) from the University of New South Wales, as well as an MBA with a major in change management from the Australian Graduate School of Management. He is passionate about improving healthcare through technology.



Yan Chow, MD, MBA--Medical Director at Amgen


Dr. Chow is Medical Director, Mobile Health, Medical Sciences Early Development Group at Amgen, the world's largest independent biotechnology firm, with 18,000 employees, revenues of $21.7B, and a focus on oncology/hematology, cardiovascular disease, inflammation, bone health, nephrology, and neuroscience. He is the lead physician scientist for early development therapeutic clinical trials and programs incorporating wearable sensors, medical devices, and mobile technology, including strategy development.


Dr. Chow has an MBA from University of California, Berkeley, Haas School of Business, where he was Valedictorian.  He has an MD from UC San Diego's School of Medicine and a Bachelor's in Biochemistry from Harvard. Dr. Chow is a physician with over two decades of primary care clinical practice experience and a deep understanding of healthcare business drivers.



Pierre Theodore @ptheodoremd - Vice President of Medical Devices at Johnson & Johnson


Pierre is a Vice President of Medical Devices at Johnson and Johnson with a focus on early stage technology development. Dr. Theodore was Associate Professor of Surgery and the Van Auken Endowed Chair in Thoracic Surgery at The University of California, San Francisco School of Medicine where he remains on the clinical faculty.


Pierre has engaged in innovation across a wide range of domains including: informatics technology, surgical oncology, and post-surgical rehabilitation.  Pierre has founded and served in leadership roles in several start-up companies devoted to health information technology and integrated care and is a co-inventor of several medical devices and drug delivery platforms.   


Pierre has served as an advisor to numerous venture capital and private equity firms in Silicon Valley, helping to guide strategy in healthcare investments across the digital health, biotech, and medical device sectors.  Pierre is a commissioned officer in the United States Navy Reserve Medical Officer Corps, holding the rank of Commander.


About Johnson and Johnson: www.jnj.com

Caring for the world, one person at a time inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Employees of the Johnson & Johnson Family of Companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.




Carl Fritjofsson, Principal, Creandum


Carl is a battle-scarred entrepreneur and investor who have seen many sides of the tech ecosystem. He started his career in management consulting and went on to co-found the digital ad network AdProfit, bootstrapping the business into one of the leading digital channels for b2b advertising in the Nordics.


Following this he joined the leading Nordic VC Creandum as a member in the investment team but soon left to co-found Wrapp, which became a portfolio company of not only Creandum but also prominent VCs like Greylock and Atomico. As COO of Wrapp, Carl was responsible for scaling the company internationally across 18 markets and raising an aggregate of $27M in VC funding.


After close to 4 years with Wrapp Carl left to work with the world's most active seed investor 500 Startups in San Francisco, coaching and mentoring early stage companies through an intensive 4 months accelerator program. In parallel to this Carl was a part-time Venture Partner with Creandum supporting its portfolio in the US market, while also launching a few startup projects within hardware and consumer internet.


As of mid 2016 Carl is a full-time Principal at Creandum being responsible for its US presence, primarily looking for European entrepreneurs scaling into the US. Carl is also a Kauffman Fellow of Class 21, and is particularly interested in foodtech, marketplaces, and any products leveraging data transparency and collaboration.




Alexander Fries, Founder & General Partner, Ecosystem Ventures


Mr. Fries founded Ecosystem Ventures in January of 2006 to address the pending need for investment and support in European technologies and pre-seed-stage companies. Mr. Fries began his career as a telecommunications analyst for Credit Suisse, and went on to build and prepare MCI WorldCom in Switzerland for the European telecommunications liberalization. 

Mr. Fries then moved on to work as Executive Vice President of sales and marketing for Advance Visual Communications, a Boston-based venture-backed content company sold to USWeb, and as a senior market manager for Europe and Latin America at the Lucent Technologies Wireless Broadband Division.

Mr. Fries brings over 20 years of progressive experience in founding, funding, and managing global businesses that provide technology, products, and services to telecommunication operators, enterprises, and consumers. His most recent entrepreneurial experiences include the co-founding of Playspan Inc (e-commerce & mirco-payment platform for online gaming) and sold to VISA International in 2011 , SDK Biotechnologies Inc.  (Diagnostics) and PURE SWISS AG (Beverage brand). In 2001 Mr. Fries also co-founded the ETH spin-off SVOX AG, a venture-backed company in Switzerland, where he led the marketing, business development, and strategic partnerships teams and sold to Nuance Communications Inc in 2011.

Mr. Fries is founder of the European-American Angels Club, a Silicon Valley-based organization that actively invests in European Start-ups. He also heads the Club Entrepreneur, a sub-chapter of the Swiss-American Chamber of Commerce in Northern California, where he is also a member of the Board of Directors. In 2010, Mr. Fries was also appointed to the Board of the Social Entrepreneurship Initiative, the first of its kind in Switzerland.

Mr. Fries received a BA in finance and an M.B.A. in telecommunications and international marketing from the University of San Francisco. Prior to moving to the United States, Mr. Fries accomplished a Swiss Banking Diploma at UBS. He has lived in Hong-Kong, Switzerland, Chile, and the USA, and speaks fluent German, Spanish, French, and English. This background allows Mr. Fries to interact professionally in a multilingual, multicultural business environment.




Moderator: Charlotte Danielsson, Esq, Executive Director of Silicon Vikings


Charlotte joined Silicon Vikings as Executive Director in January 2015. Charlotte has a Juris Doctorate from Stanford Law School and a BA in Political Science & Economics from UC Berkeley, where she graduated with honors in the major and Distinction in General Scholarship from the university.  Charlotte has practiced business and immigration law for technology companies since 1998 specializing in helping foreign companies establish themselves in the US.  


Thank you to our Event Host:

Thank you to our Event Partner: